| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,259 |
20,810 |
$1.08M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,938 |
6,359 |
$469K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,257 |
1,034 |
$426K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,455 |
3,330 |
$255K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,735 |
7,131 |
$206K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,894 |
2,767 |
$192K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,519 |
2,349 |
$164K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,108 |
1,972 |
$127K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,160 |
7,637 |
$111K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,426 |
1,339 |
$103K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
309 |
250 |
$99K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,728 |
4,454 |
$66K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,691 |
1,491 |
$64K |
| 92551 |
|
7,790 |
7,463 |
$61K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
634 |
550 |
$47K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
665 |
586 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,434 |
2,922 |
$37K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
764 |
384 |
$34K |
| 90620 |
|
862 |
801 |
$14K |
| 99173 |
|
7,905 |
7,469 |
$14K |
| 90651 |
|
1,382 |
1,314 |
$10K |
| 99188 |
|
497 |
464 |
$10K |
| 90474 |
|
879 |
834 |
$8K |
| 83655 |
|
723 |
539 |
$6K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
101 |
74 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
401 |
381 |
$5K |
| 99215 |
Prolong outpt/office vis |
58 |
57 |
$5K |
| 0001A |
|
123 |
115 |
$5K |
| 0002A |
|
126 |
111 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
328 |
307 |
$4K |
| 87634 |
|
72 |
50 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
175 |
166 |
$2K |
| 90670 |
|
1,976 |
1,770 |
$2K |
| 90734 |
|
590 |
558 |
$2K |
| 99499 |
|
162 |
131 |
$2K |
| 85018 |
|
805 |
642 |
$1K |
| 0071A |
|
53 |
36 |
$1K |
| 95115 |
|
169 |
67 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
16 |
$1K |
| 90473 |
|
105 |
101 |
$980.48 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20 |
19 |
$975.07 |
| 99381 |
|
12 |
12 |
$839.19 |
| 90688 |
|
603 |
542 |
$744.21 |
| 0072A |
|
16 |
15 |
$677.04 |
| 90619 |
|
575 |
531 |
$605.36 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
16 |
16 |
$526.35 |
| 90715 |
|
327 |
307 |
$322.60 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
31 |
29 |
$314.88 |
| 81025 |
|
43 |
39 |
$227.16 |
| 90716 |
|
248 |
227 |
$194.84 |
| 90686 |
|
297 |
282 |
$157.86 |
| 90697 |
|
348 |
308 |
$150.00 |
| 90621 |
|
17 |
12 |
$149.14 |
| 90660 |
|
35 |
25 |
$147.72 |
| 96160 |
|
138 |
84 |
$113.26 |
| 90680 |
|
892 |
806 |
$97.06 |
| 90672 |
|
154 |
150 |
$90.00 |
| 90658 |
|
91 |
84 |
$87.44 |
| 90710 |
|
675 |
605 |
$81.25 |
| 90707 |
|
253 |
234 |
$70.92 |
| 96161 |
|
24 |
12 |
$65.12 |
| 81002 |
|
16 |
12 |
$32.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
12 |
$13.92 |
| 90633 |
|
2,631 |
2,407 |
$4.52 |
| 90380 |
|
13 |
12 |
$0.01 |
| 90700 |
|
332 |
302 |
$0.00 |
| 90685 |
|
34 |
33 |
$0.00 |
| 90687 |
|
84 |
75 |
$0.00 |
| 91300 |
|
285 |
264 |
$0.00 |
| 90713 |
|
72 |
62 |
$0.00 |
| 90744 |
|
437 |
397 |
$0.00 |
| 90698 |
|
1,194 |
1,079 |
$0.00 |
| 91307 |
|
96 |
62 |
$0.00 |
| 97802 |
|
16 |
15 |
$0.00 |